Clinical Guidance and Pathways
On this page you will find clinical guidance and treatment pathways that have been approved by the Humber and North Yorkshire Integrated Medicines Optimisation Committee (HNY IMOC).
General
- NICE Tirzepatide FAQs For Patients – December 2024
- HNY patient information leaflet – private prescriptions – May 2024
- HNY Guidance – 7 day prescriptions and monitored dosage systems – September 2024
Diabetes
- Humber and North Yorkshire Type 2 Diabetes Algorithm
- Humber and North Yorkshire Blood Glucose Meter Formulary
- Humber and North Yorkshire Continuous Glucose Monitoring Policy
Respiratory
Diagnosing and Treating Asthma.
High quality asthma care, that is sustainable and consistent, for patients in the Humber and North Yorkshire area can be found here.
Palliative Care
- A Guide to Symptom Management in Palliative Care
- Obtaining urgently required end of life medicines – guidance for North Yorkshire and York places July 2024
Community Pharmacy Clinical Protocols
- Humber and North Yorkshire Community Pharmacy Independent Prescribing Pathfinder CVD – Primary Prevention Lipids Therapy
- Humber and North Yorkshire Community Pharmacy Independent Prescribing Pathfinders Stakeholder Briefing
- Humber and North Yorkshire Community Pharmacy Independent Prescribing Pathfinders Extended Minor Illness Clinical Protocol
- Humber and North Yorkshire Community Pharmacy Hypertension Case Finding Escalation Protocol
- Humber and North Yorkshire Community Pharmacy Independent Prescribing Pathfinders Hypertension Clinical Protocol
- Humber and North Yorkshire Community Pharmacy Independent Prescribing Pathfinder CVD Primary Prevention Lipids Therapy
- Humber and North Yorkshire Community Pharmacy Independent Prescribing Pathfinder SQuaDROM Addressing Polypharmacy Protocol
- Humber and North Yorkshire Community Pharmacy Independent Prescribing Pathfinder SQuaDROM Unavailable Medicines Protocol
Ophthalmology